Literature DB >> 17130140

HIV outbreak among injecting drug users in the Helsinki region: social and geographical pockets.

Pia Kivelä1, Anneke Krol, Susan Simola, Mari Vaattovaara, Pekka Tuomola, Henrikki Brummer-Korvenkontio, Matti Ristola.   

Abstract

BACKGROUND: Incidence of newly diagnosed HIV infections among injecting drug users (IDUs) in Helsinki rose from 0 per 100,000 inhabitants in 1997 to 2.9 in 1998 and to 11.1 in 1999. Thereafter incidence declined to 2.1 in 2003.
METHODS: Data were collected from interviews with HIV-positive IDUs who attended the University Hospital in Helsinki from 1998 until 2003. We studied the sociodemographic profile and spatial distribution of IDUs who were diagnosed in the beginning of the outbreak and those diagnosed later. The indicator for the spatial differentiation within the metropolitan area is % employed males aged 25-64.
RESULTS: The outbreak occurred among a marginalized population of IDUs characterized by a long history of injecting drug use (10.7 years), mean age 32 years, homelessness (66.3%), history of imprisonment (74.7%) and psychiatric hospital care (40.6%). Compared with 98 early cases diagnosed during the first 2 years until 2000, 47 recent cases diagnosed after 2001 were 4 years older, and as marginalized. Except for the city centre, both early and recent cases had been living or using drugs in the same deprived neighbourhoods with the highest unemployment rates. Up to 40% of cases in the two big geographical clusters did not have contact with the city centre, where the needle exchange services were available.
CONCLUSIONS: The Finnish HIV outbreak is restricted socially to a very marginalized IDU population, and spatially to local pockets of poverty. In low prevalence countries, prevention programs should be targeted early at high-risk areas and populations.

Entities:  

Mesh:

Year:  2006        PMID: 17130140     DOI: 10.1093/eurpub/ckl252

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  7 in total

1.  Dynamics of two separate but linked HIV-1 CRF01_AE outbreaks among injection drug users in Stockholm, Sweden, and Helsinki, Finland.

Authors:  Helena Skar; Maria Axelsson; Ingela Berggren; Anders Thalme; Katarina Gyllensten; Kirsi Liitsola; Henrikki Brummer-Korvenkontio; Pia Kivelä; Erika Spångberg; Thomas Leitner; Jan Albert
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

2.  Estonia at the threshold of the fourth decade of the AIDS era in Europe.

Authors:  Kaja-Triin Laisaar; Radko Avi; Jack DeHovitz; Anneli Uusküla
Journal:  AIDS Res Hum Retroviruses       Date:  2011-01-11       Impact factor: 2.205

Review 3.  Housing Status, Medical Care, and Health Outcomes Among People Living With HIV/AIDS: A Systematic Review.

Authors:  Angela A Aidala; Michael G Wilson; Virginia Shubert; David Gogolishvili; Jason Globerman; Sergio Rueda; Anne K Bozack; Maria Caban; Sean B Rourke
Journal:  Am J Public Health       Date:  2015-11-12       Impact factor: 9.308

Review 4.  Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.

Authors:  Georgios K Nikolopoulos; Evangelia-Georgia Kostaki; Dimitrios Paraskevis
Journal:  Infect Genet Evol       Date:  2016-06-07       Impact factor: 3.342

5.  Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia.

Authors:  Anneli Uusküla; Don C Des Jarlais; Mart Kals; Kristi Rüütel; Katri Abel-Ollo; Ave Talu; Igor Sobolev
Journal:  BMC Public Health       Date:  2011-06-30       Impact factor: 3.295

6.  Serodiagnosis of primary infections with human parvovirus 4, Finland.

Authors:  Anne Lahtinen; Pia Kivelä; Lea Hedman; Arun Kumar; Anu Kantele; Maija Lappalainen; Kirsi Liitsola; Matti Ristola; Eric Delwart; Colin Sharp; Peter Simmonds; Maria Söderlund-Venermo; Klaus Hedman
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

Review 7.  Analysis of duration of risk behaviour for key populations: a literature review.

Authors:  Erika Fazito; Paloma Cuchi; Mary Mahy; Tim Brown
Journal:  Sex Transm Infect       Date:  2012-12       Impact factor: 3.519

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.